Replies to post #106723 on Biotech Values

[DewDiligence]

Correct. The real question (and the reason I made the subordinate question you answered a quiz) is whether GILD’s assertion vis-à-vis non-compliance in the TMC278 phase-3 studies holds water. I’m inclined to think that it doesn’t. Do you agree?